BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31649556)

  • 1. A Conserved Requirement for
    Rathje CC; Randle SJ; Al Rawi S; Skinner BM; Nelson DE; Majumdar A; Johnson EEP; Bacon J; Vlazaki M; Affara NA; Ellis PJ; Laman H
    Front Physiol; 2019; 10():1278. PubMed ID: 31649556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of an FBXO7 patient mutation reveals Fbxo7 and PI31 co-regulate proteasomes and mitochondria.
    Al Rawi S; Simpson L; Agnarsdóttir G; McDonald NQ; Chernuha V; Elpeleg O; Zeviani M; Barker RA; Spiegel R; Laman H
    FEBS J; 2024 Jun; 291(12):2565-2589. PubMed ID: 38466799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitor.
    Kirk R; Laman H; Knowles PP; Murray-Rust J; Lomonosov M; Meziane el K; McDonald NQ
    J Biol Chem; 2008 Aug; 283(32):22325-35. PubMed ID: 18495667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved F box regulatory complex controls proteasome activity in Drosophila.
    Bader M; Benjamin S; Wapinski OL; Smith DM; Goldberg AL; Steller H
    Cell; 2011 Apr; 145(3):371-82. PubMed ID: 21529711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the FP domain of Fbxo7 reveals a novel mode of protein-protein interaction.
    Shang J; Wang G; Yang Y; Huang X; Du Z
    Acta Crystallogr D Biol Crystallogr; 2014 Jan; 70(Pt 1):155-64. PubMed ID: 24419388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FBXO7 homologue nutcracker and binding partner PI31 in Drosophila melanogaster models of Parkinson's disease.
    Merzetti EM; Dolomount LA; Staveley BE
    Genome; 2017 Jan; 60(1):46-54. PubMed ID: 27936908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice.
    Vingill S; Brockelt D; Lancelin C; Tatenhorst L; Dontcheva G; Preisinger C; Schwedhelm-Domeyer N; Joseph S; Mitkovski M; Goebbels S; Nave KA; Schulz JB; Marquardt T; Lingor P; Stegmüller J
    EMBO J; 2016 Sep; 35(18):2008-25. PubMed ID: 27497298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, purification and crystallization of the FP domain of the human F-box protein Fbxo7.
    Shang J; Wang G; Yang Y; Huang X; Du Z
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Oct; 69(Pt 10):1097-9. PubMed ID: 24100556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FP domains of PI31 and Fbxo7 have the same protein fold but very different modes of protein-protein interaction.
    Shang J; Huang X; Du Z
    J Biomol Struct Dyn; 2015; 33(7):1528-38. PubMed ID: 25266262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The parkinsonism-associated protein FBXO7 cooperates with the BAG6 complex in proteasome function and controls the subcellular localization of the complex.
    Wang Q; Crnković V; Preisinger C; Stegmüller J
    Biochem J; 2021 Jun; 478(12):2179-2199. PubMed ID: 34060591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXO7 sensitivity of phenotypic traits elucidated by a hypomorphic allele.
    Ballesteros Reviriego C; Clare S; Arends MJ; Cambridge EL; Swiatkowska A; Caetano S; Abu-Helil B; Kane L; Harcourt K; Goulding DA; Gleeson D; Ryder E; Doe B; White JK; van der Weyden L; Dougan G; Adams DJ; Speak AO
    PLoS One; 2019; 14(3):e0212481. PubMed ID: 30840666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characteristics of FBXO7 and its role in human diseases.
    Zhong Y; Li J; Ye M; Jin X
    Gene; 2023 Jan; 851():146972. PubMed ID: 36261086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective erythropoiesis in a mouse model of reduced Fbxo7 expression due to decreased p27 expression.
    Randle SJ; Nelson DE; Patel SP; Laman H
    J Pathol; 2015 Oct; 237(2):263-72. PubMed ID: 26095538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
    Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
    Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15).
    Zhao T; De Graaff E; Breedveld GJ; Loda A; Severijnen LA; Wouters CH; Verheijen FW; Dekker MC; Montagna P; Willemsen R; Oostra BA; Bonifati V
    PLoS One; 2011 Feb; 6(2):e16983. PubMed ID: 21347293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic degradation of heat shock protein A2 occurs in response to oxidative stress in male germ cells of the mouse.
    Bromfield EG; Aitken RJ; McLaughlin EA; Nixon B
    Mol Hum Reprod; 2017 Feb; 23(2):91-105. PubMed ID: 27932549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI31 Is an Adaptor Protein for Proteasome Transport in Axons and Required for Synaptic Development.
    Liu K; Jones S; Minis A; Rodriguez J; Molina H; Steller H
    Dev Cell; 2019 Aug; 50(4):509-524.e10. PubMed ID: 31327739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The testis-specific proteasome subunit Prosalpha6T of D. melanogaster is required for individualization and nuclear maturation during spermatogenesis.
    Zhong L; Belote JM
    Development; 2007 Oct; 134(19):3517-25. PubMed ID: 17728345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of spermatogenic process by Lkb1 isoforms in mouse testis.
    Kong F; Wang M; Huang X; Yue Q; Wei X; Dou X; Peng X; Jia Y; Zheng K; Wu T; Yan J; Li J
    Cell Death Dis; 2017 Oct; 8(10):e3121. PubMed ID: 29022902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel dominant mutation Dspd leads to a severe spermiogenesis defect in mice.
    Kai M; Irie M; Okutsu T; Inoue K; Ogonuki N; Miki H; Yokoyama M; Migishima R; Muguruma K; Fujimura H; Kohda T; Ogura A; Kaneko-Ishino T; Ishino F
    Biol Reprod; 2004 Apr; 70(4):1213-21. PubMed ID: 14695912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.